The Safety and Efficacy of Double-target CART-19 and 20 Cells in Non-Hodgkin's Lymphoma (NHL)
Clinical trial NCT06160362 · UNKNOWN
Trial details
- NCT number
- NCT06160362
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-31
- Primary completion
- 2025-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.